S6G5T-3 / Sol-Gel - LARVOL DELTA

Tretinoin 0.1% and Benzoyl Peroxide 3% Cream for the Treatment of Facial Acne Vulgaris. (PubMed, Ann Pharmacother) - "A systematic review of the literature was performed using the terms Twyneo OR tretinoin and benzoyl peroxide OR S6G5T-3 in MEDLINE (PubMed) and EMBASE. Tretinoin 0.1%-benzoyl peroxide 3% cream is safe and effective for the treatment of moderate-to-severe acne. Long-term trial data on efficacy and tolerability are not yet available."

Clinical • Journal • Review • Acne Vulgaris • Dermatology • Pain

A Study of S6G5T 3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) - P3; N=434; Completed; Sponsor: Sol-Gel Technologies, Ltd.; Recruiting ➔ Completed; Trial completion date: Nov 2020 ➔ Dec 2019

Clinical • Trial completion • Trial completion date

A Study of S6G5T-3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) - P3; N=424; Completed; Sponsor: Sol-Gel Technologies, Ltd.; Recruiting ➔ Completed; Trial completion date: Dec 2020 ➔ Dec 2019

Clinical • Trial completion • Trial completion date

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 (clinicaltrials.gov) - P1b; N=62; Completed; Sponsor: Sol-Gel Technologies, Ltd.; Recruiting ➔ Completed

Clinical • Trial completion

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 (clinicaltrials.gov) - P1b; N=50; Recruiting; Sponsor: Sol-Gel Technologies, Ltd.

Clinical • New P1 trial